US Broker Ratings

Rhythm Pharmaceuticals (RYTM) Stock Analysis: Unpacking the 23% Potential Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is carving out a niche in the biopharmaceutical landscape by targeting rare neuroendocrine diseases with its innovative treatments. With a focus on conditions like POMC..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating a Complex Biotech Landscape with a 7.53 Forward P/E Ratio

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a noteworthy player in the biotechnology sector, focusing on transformative therapies for rare genetic diseases. Despite navigating a challenging market environment, the company..

Alkermes plc (ALKS) Stock Analysis: A Biopharmaceutical Innovator with a 54% Potential Upside

Alkermes plc (NASDAQ: ALKS), a leader in the healthcare sector specializing in drug manufacturing, particularly in specialty and generic pharmaceuticals, has caught the attention of investors with its significant growth..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Volatility with Strategic Partnerships and a Diverse Pipeline

Moderna, Inc. (NASDAQ: MRNA), a leading player in the biotechnology sector, remains at the forefront of medical innovation with its groundbreaking work in messenger RNA (mRNA) medicines. However, the current..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with a 12.42% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a leading player in the biotechnology sector, has been making waves in the healthcare industry with its focus on transformative medicines aimed at treating genetic..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A Deep Dive into Its 362% Revenue Growth and Potential Upside

Madrigal Pharmaceuticals, Inc. (MDGL) is capturing the attention of investors with its impressive revenue growth and promising analyst ratings. As a key player in the biotechnology sector, Madrigal focuses on..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a Solid 7.9% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Molina Healthcare Inc (NYSE: MOH) presents an intriguing prospect. With a robust market cap of $8.87 billion, this Long Beach, California-based company..

BrightSpring Health Services (BTSG) Stock Analysis: Exploring Growth in the Booming Healthcare Sector

BrightSpring Health Services, Inc. (BTSG) is carving out a significant niche in the healthcare sector, specifically within health information services. With a market capitalization of $6.76 billion, BrightSpring is well-positioned..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unveiling a 15% Potential Upside for Investors

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector, is making waves with its recent stock performance and forward-looking potential. As a key player in the medical devices..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Promising Biotech with 137% Upside Potential Awaits Investors

Investors in the biotechnology sector are no strangers to high-risk, high-reward scenarios, and Soleno Therapeutics, Inc. (NASDAQ: SLNO) presents an intriguing opportunity. With a market cap of $2.57 billion and..

Henry Schein, Inc. (HSIC): Exploring Analyst Consensus and Growth Potential in the Medical Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC), a leader in the healthcare sector, is drawing the attention of investors as a stalwart in the medical distribution industry. With a robust market capitalization..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Unpacking the Upside Potential in Transformative Biotech

In the dynamic world of biotechnology, Akero Therapeutics, Inc. (NASDAQ: AKRO) has been capturing investor attention with its focused strategy on developing groundbreaking treatments for metabolic diseases. Operating out of..

Vaxcyte, Inc. (PCVX) Investor Outlook: Exploring a Potential 98% Upside in Biotechnology

Investors and analysts alike are taking a keen interest in Vaxcyte, Inc. (PCVX), a burgeoning force in the biotechnology sector with a market capitalization of $6.08 billion. Specializing in the..

Alcon Inc. (ALC) Stock Analysis: Unveiling a 15% Potential Upside in Eye-Care Innovation

Alcon Inc. (NYSE: ALC), a global leader in the eye care sector, stands as a formidable player in the healthcare industry, with an impressive market cap of $39.43 billion. Headquartered..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Biotechnology Innovator with 434% Revenue Growth Awaits Investor Attention

Avidity Biosciences, Inc. (NASDAQ: RNA) is a promising name in the biotechnology sector, captivating investor attention with its impressive revenue growth and innovative RNA therapeutic solutions. Based in San Diego,..

Chemed Corp (CHE) Stock Analysis: Valuation Insights and 31.91% Potential Upside

Investors with a keen interest in the healthcare sector may find Chemed Corp (NYSE: CHE) a compelling prospect, particularly given its significant potential upside of 31.91%. With a robust market..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Innovator with Strong Buy Ratings and Revenue Growth

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a leading player within the biotechnology sector, captivating investor interest with its innovative approach to genetic medicine. Based in Pittsburgh, Pennsylvania, this..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Unveiling a 31.54% Potential Upside in Biotech

Cytokinetics, Incorporated (NASDAQ: CYTK) is making waves in the biotechnology sector, presenting a compelling opportunity for investors seeking exposure to cutting-edge developments in muscle activators and inhibitors. With a market..

Revolution Medicines, Inc. (RVMD): Investor Outlook on a Promising Precision Oncology Play with Strong Buy Ratings

Revolution Medicines, Inc. (NASDAQ: RVMD) has caught the attention of investors with its strong foothold in the biotechnology sector, particularly in the niche area of precision oncology. Headquartered in Redwood..

RadNet, Inc. (RDNT) Investor Outlook: Analyzing a 19.61% Potential Upside in the Healthcare Sector

Investors in the healthcare sector may want to keep a close eye on RadNet, Inc. (NASDAQ: RDNT), a key player in the diagnostics and research industry. Headquartered in Los Angeles,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds